ASP5878

ASP5878 Suppliers list
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Shanghai JiYi Biotechnology Co. Ltd.  
Tel: 13621943973
Email: sales@shjiyipharmatech.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com

ASP5878 manufacturers

  • ASP5878
  • ASP5878 pictures
  • $60.00
  • 2026-07-27
  • CAS:1453208-66-6
  • Purity: 99.89%
  • Supply Ability: 10g
ASP5878 Basic information
Product Name:ASP5878
Synonyms:ASP5878;ASP-5878 (ASP5878;ASP5878; ASP 5878; ASP-5878;ASP 5878,Inhibitor,FGFR,ASP5878,Fibroblast growth factor receptor,inhibit;1H-Pyrazole-1-ethanol, 4-[[5-[(2,6-difluoro-3,5-dimethoxyphenyl)methoxy]-2-pyrimidinyl]amino]-;2-(4-((5-((2,6-Difluoro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)ethan-1-ol;ASP5878, 10 mM in DMSO
CAS:1453208-66-6
MF:C18H19F2N5O4
MW:407.37
EINECS:
Product Categories:
Mol File:1453208-66-6.mol
ASP5878 Structure
ASP5878 Chemical Properties
Boiling point 645.3±65.0 °C(Predicted)
density 1.41±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : ≥ 250 mg/mL (613.69 mM);Water : < 0.1 mg/mL (insoluble)
pka14.41±0.10(Predicted)
form Solid
color Light yellow to yellow
Safety Information
MSDS Information
ASP5878 Usage And Synthesis
UsesASP5878 is a selective inhibitor of FGFR1, 2, 3 and 4.
in vivo

ASP5878 (3 mg/kg, orally, once daily) shows antitumor activity in a Hep3B2.1-7 subcutaneous xenograft and HCC orthotopic xenograft mouse model[1].
ASP5878 induces shrinkage of FGF19-expressing HCC xenograft model[1].

Animal Model:Four-week-old male nude mice (CAnN.Cg-Foxn1nu/CrlCrlj [nu/nu]) (Hep3B2.1-7 cells inoculated subcutaneously)[1].
Dosage:3 mg/kg.
Administration:Orally once daily from days 14 to 52.
Result:Induced tumor regression by 9% and 88% at 1 and 3 mg/kg, respectively, without affecting the body weight for 14 days.
Induced the suppression of FGFR4 phosphorylation, mobility shift of FRS2, and suppression of ERK phosphorylation.
Animal Model:HCC orthotopic xenograft model (mouse)[1].
Dosage:3 mg/kg.
Administration:Orally once daily for 24 days.
Result:Exhibited a lower tumor burden than vehicle- and sorafenibtreated mice.
Induced sustained tumor regression without tumor regrowth.
IC 50FGFR1: 0.47 nM (IC50); FGFR2: 0.6 nM (IC50); FGFR3: 0.74 nM (IC50); FGFR4: 3.5 nM (IC50)
ASP5878 Preparation Products And Raw materials
Tag:ASP5878(1453208-66-6) Related Product Information
FIIN-2 FIIN-3 DCC-3014 PD0166285 PD 173074 FGFR-1 alpha (iiic) protein, human (biotinylated, HEK293, His-AVI)